(Press-News.org) Highlights:
Infections by antimicrobial resistant (AMR) pathogens are a leading cause of death worldwide, with more than 1 million deaths annually, highlighting the need for new treatments.
Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens.
Infuzide works against known, problematic gram-positive pathogens.
In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.
Washington, D.C.—Antimicrobial resistance directly causes more than 1 million deaths every year and contributes to more than 35 million more, according to the World Health Organization. Staphylococcus aureus and Enterococcus sp., 2 gram-positive pathogens highly likely to develop resistance to known treatments, can cause dangerous hospital-acquired and community-acquired infections.
This week in Microbiology Spectrum, researchers describe a newly synthesized compound called infuzide that shows activity against antimicrobial resistant strains of S. aureus and Enterococcus in laboratory and mouse tests. In addition, the findings suggest that infuzide kills bacteria in ways that differ from other antimicrobials, which may help keep resistance at bay.
Infuzide emerged from more than a decade of work by interdisciplinary researchers looking for ways to create compounds that could act against pathogens in ways similar to known pharmaceutical compounds. Those include hydrazones, inorganic synthesized compounds that previous studies have shown to demonstrate antibacterial activity, including against resistant strains. The researchers synthesized 17 new compounds that contained hydrazones, and among those infuzide showed activity against gram-positive S. aureus and Enterococcus.
“We started the project as a collaboration, looking for ways to synthesize compounds and connecting them with compounds that might have biological activities,” said medicinal chemist Michel Baltas, Ph.D., from the Laboratoire de Chimie de Coordination at the University of Toulouse in France. Baltas co-led the new work, along with Sidharth Chopra, Ph.D., from the CSIR-Central Drug Research Institute in Lucknow, India.
The researchers found that infuzide specifically attacks bacterial cells. In lab tests, they compared the antimicrobial effects of infuzide against vancomycin, a powerful antibiotic representing the standard of care in treating resistant infections. They found that infuzide more quickly and effectively reduced the size of bacterial colonies than the standard drug. In tests of resistant S. aureus infections on the skin of mice, the compound effectively reduced the bacterial population. The reduction was even higher, the researchers reported, when infuzide was combined with linezolid, a synthetic antibiotic.
Infuzide did not show significant activity against gram-negative pathogens, though Baltas said the group is looking for small changes to infuzide that might expand its antimicrobial activity.
The researchers synthesized the compounds without the need of solvents, which can be expensive and environmentally hazardous. The simplicity of the chemical reactions, Baltas said, would make it easy to make large quantities to be used in new treatments. “I am sure the same reactions can scale up.”
In addition, the group has been investigating the effects of synthesized compounds on other infectious diseases, including tuberculosis. “We have many other candidates to make antimicrobial compounds,” Baltas said.
###
The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of over 37,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to all audiences.
END
Synthetic compound shows promise against multidrug resistance
2025-06-02
ELSE PRESS RELEASES FROM THIS DATE:
Researchers recreate ancient Egyptian blues
2025-06-02
PULLMAN, Wash.--A team of Washington State University-led researchers has recreated the world's oldest synthetic pigment, called Egyptian blue, which was used in ancient Egypt about 5,000 years ago.
Reporting in the journal, NPJ Heritage Science, the researchers used a variety of raw materials and heating times to develop 12 recipes for the pigments, providing useful information for archaeologists and conservation scientists who study the ancient Egyptian materials. The work was done in collaboration with Carnegie Museum of ...
Immunotherapy before surgery improves lung cancer survival in global clinical trial led by Irish cancer specialist
2025-06-02
Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved long term survival compared to those who received chemotherapy alone, at 5 years after completing treatment. Prof. Patrick Forde of the Trinity St. James’s Cancer Institute (TSJCI), Trinity College Dublin School of Medicine presented the findings at the American ...
S2302 Pragmatica-Lung reports out as model for faster, leaner, more representative trials
2025-06-02
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary question, finding that the investigational combination it tested did not significantly extend overall survival compared to standard of care treatments.
Importantly, the phase 3 trial’s rapid development and implementation, coupled with its successful enrollment of a group of patients broadly representative of the larger U.S. population, establish Pragmatica-Lung as a paradigm-shifting model for the design and conduct of future large randomized studies.
Results will be presented ...
New Venus observation mission - World's first long-term planetary cubesat study by Korea’s Institute for Basic Science and NanoAvionics
2025-06-02
Daejeon, South Korea, and Vilnius, Lithuania, 2 June 2025 – Kongsberg NanoAvionics (NanoAvionics), a leading small satellite bus manufacturer and mission integrator, has been selected by the Institute for Basic Science (IBS) in South Korea to build the first CubeSat for the world’s first long-term planetary science campaign which will use a series of CubeSats to monitor Venus from low Earth orbit.
This long-term Venus observation initiative, the CLOVE project (Chasing the Long-term Variability of Our Nearest Neighbor Planet ...
Brain training game offers new hope for drug-free pain management
2025-06-02
A trial of an interactive game that trains people to alter their brain waves has shown promise as a treatment for nerve pain – offering hope for a new generation of drug-free treatments.
The PainWaive technology, developed by UNSW Sydney researchers, teaches users how to regulate abnormal brain activity linked to chronic nerve pain, offering a potential in-home, non-invasive alternative to opioids.
A recent trial of the technology, led by Professor Sylvia Gustin and Dr Negin Hesam-Shariati from UNSW Sydney’s NeuroRecovery Research Hub, has delivered promising results, published in the Journal of Pain.
The study compared ...
Attachment theory: A new lens for understanding human-AI relationships
2025-06-02
Artificial intelligence (AI) is ubiquitous in this era. As a result, human-AI interactions are becoming more frequent and complex, and this trend is expected to accelerate soon. Therefore, scientists have made remarkable efforts to better understand human-AI relationships in terms of trust and companionship. However, these man-machine interactions can possibly also be understood in terms of attachment-related functions and experiences, which have traditionally been used to explain human interpersonal bonds.
In an innovative work, which incorporates two pilot studies and one formal study, a group of researchers from Waseda University, Japan, including Research ...
Self-powered artificial synapse mimics human color vision
2025-06-02
As artificial intelligence and smart devices continue to evolve, machine vision is taking an increasingly pivotal role as a key enabler of modern technologies. Unfortunately, despite much progress, machine vision systems still face a major problem: processing the enormous amounts of visual data generated every second requires substantial power, storage, and computational resources. This limitation makes it difficult to deploy visual recognition capabilities in edge devices—such as smartphones, drones, or autonomous vehicles.
Interestingly, the human visual system ...
Circadian preference is associated with impulsivity in adolescents
2025-06-02
DARIEN, IL – A new study to be presented at the SLEEP 2025 annual meeting found that adolescents who prefer to sleep and wake up later (“night owls”) reported greater impulsivity than those who prefer to sleep and wake up earlier (“morning larks”).
Results show that adolescents with self-reported evening preference, or “night owl” tendencies, reported greater negative urgency and lack of perseverance, which are two aspects of impulsivity. This means that they were more likely to act impulsively when experiencing negative emotions and quit difficult tasks. In contrast, ...
Space pebbles and rocks play pivotal role in giant planet’s formation
2025-06-02
Scientists analysing an ultra-hot giant planet believe it was formed by absorbing lightweight gases like methane evaporating from tiny space pebbles, whilst being bombarded with large rocky objects.
Using the James Webb Space Telescope (JWST) to explore the atmosphere of WASP-121b, researchers successfully detected water (H₂O), carbon monoxide (CO), and silicon monoxide (SiO) in the side facing its star or ‘dayside’. They also found methane (CH₄) in the planet’s ‘nightside’ atmosphere.
Publishing ...
Still on the right track? Researchers at the University of Graz enable reliable monitoring of the Paris climate goals
2025-06-02
In the Paris Agreement of 2015, the international community of countries agreed to limit global warming to well below 2 °C, and preferably to 1.5 °C, compared to pre-industrial levels. This refers to the increase in global surface air temperature, inspected at any time of interest as an average over 20 years. The latest IPCC report expected the 1.5 °C threshold to be reached between 2030 and 2035. Climate researcher Gottfried Kirchengast from the Wegener Center and Institute of Physics at the University of Graz now has to revise this estimate: “Our ...